A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia

Conditions:   Recurrent Acute Leukemia of Ambiguous Lineage;   Recurrent Acute Lymphoblastic Leukemia;   Recurrent Mixed Phenotype Acute Leukemia;   Refractory Acute Leukemia of Ambiguous Lineage;   Refractory Acute Lymphoblastic Leukemia;   Refractory Mixed Phenotype Acute Leukem ia Interventions:   Procedure: Biospecimen Collection;   Drug: Calaspargase Pegol-mknl;   Drug: Cytarabine;   Procedure: Echocardiography;   Drug: Fludarabine Phosphate;   Drug: Hydrocortisone Sodium Succinate;   Drug: Methotrexate;   Procedure: Multigated Acquisition Scan;   Drug: Pegasparg ase;   Drug: Prednisolone;   Drug: Prednisone;   Drug: Revumenib;   Drug: Vincristine Sulfate Sponsor:   Children's Oncology Group Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials